Here, we showed that GRP78 gene expression in blood was higher in SARS-CoV-2 (+) versus SARS-CoV-2 (−) pneumonia patients, providing further indication that GRP78 might be a good molecular target to treat Covid-19. The gene discussed is HSPA5; the disease is susceptibility to pneumonia measurement.